Published pediatric randomized drug trials in developing countries, 1996-2002

Area of Science:

• Pediatric pharmacology
• Global health research
• Clinical trial methodology

Background:

• The majority of childhood disease burden is in developing nations.
• Few pediatric randomized controlled trials (RCTs) are conducted in these regions.
• Children in developing countries require access to appropriate medications for prevalent diseases.

Purpose of the Study:

• To identify pediatric therapeutic RCTs conducted in developing countries.
• To assess the appropriateness of studied diseases and interventions for major health issues in these regions.
• To examine the safety monitoring practices reported in these trials.

Main Methods:

• Analysis of a database of pediatric RCTs published between 1996 and 2002.
• Categorization of trial settings based on Human Development Index (HDI).
• Inclusion of disease (ICD-10) and drug (ATC) classifications, funding sources, and ethical approval data.

Main Results:

• 158 (22%) of 733 RCTs were set in low/medium HDI countries.
• Studied diseases were appropriate, with 56% focusing on infectious and parasitic diseases.
• Trials in developing countries showed significantly less mention of ethical approval and safety monitoring compared to high HDI countries.

Conclusions:

• Pediatric drug RCTs in developing countries address relevant diseases but are fewer in number.
• The reporting quality of RCTs from developing countries needs enhancement, particularly concerning safety monitoring.
• Ensuring adequate safety data is crucial for pediatric drug trials in resource-limited settings.